Schulze-Neick, Ingram <br/><br/>
Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.  [electronic resource] 

 -  Circulation  Sep 2003 
 - II167-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.0000087384.76615.60  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-GMP Phosphodiesterases--antagonists & inhibitors<br/>Administration, Inhalation<br/>Adolescent<br/>Blood Pressure--drug effects<br/>Cardiac Catheterization<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cyclic GMP--blood<br/>Cyclic Nucleotide Phosphodiesterases, Type 5<br/>Heart Defects, Congenital--drug therapy<br/>Hemodynamics--drug effects<br/>Humans<br/>Infant<br/>Infusions, Intravenous<br/>Nitric Oxide--administration & dosage<br/>Phosphodiesterase Inhibitors--administration & dosage<br/>Piperazines--administration & dosage<br/>Postoperative Period<br/>Pulmonary Artery--drug effects<br/>Pulmonary Circulation--drug effects<br/>Purines<br/>Sildenafil Citrate<br/>Sulfones<br/>Vascular Resistance--drug effects<br/>Vasodilator Agents--administration & dosage